NOVO

📅 Upcoming

🕒 Recent(90d)

News

• 5 new drug launches that defied industry expectations
  A clearly superior clinical profile, reasonable pricing and easy access has helped a handful of recently approved therapies achieve impressive launches.
  biospace · 5h ago
• Behind the scenes of 3 Big Pharma layoffs
  Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some aspects of their experiences, such as severance and outplacement resource…
  biospace · 6h ago
• STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
  Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.
  stat · 15h ago
• Lilly's ads can continue after Novo challenge, judge rules
  Novo Nordisk has suffered another setback in its uphill battle against Eli Lilly in the booming obesity drug market after a US judge rejected its attempt to block television ads that Novo alleges a…
  endpoints · 15h ago
• Court rejects Novo bid to block Lilly obesity drug ads
  Novo failed to prove that Lilly’s campaign — which featured claims of obesity drug superiority — meaningfully harmed the Danish company’s sales, a federal judge ruled.
  biopharma_dive · 18h ago
• Teva closing New Jersey manufacturing facility, laying off 61 employees
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 19h ago
• STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
  Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
  stat · 19h ago
• STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more
  A U.S. judge rejected a bid to block ‌Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs
  stat · 20h ago
• Experts offer insights on de novo requests, MDUFA VI changes
  BOSTON – An expert and officials from the US Food and Drug Administration (FDA) offered tips for de novo classification requests and reviewed some of the changes related to de novos being proposed…
  raps · 1d ago
• Recon: FDA approves treatments for prostate cancer, Crohn’s disease; US judge refuses to halt Lilly weight-loss drug ads
  Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
  raps · 1d ago